Venture-Med Angel Investment Group is a membership organization of accredited investors dedicated to funding and mentoring new healthcare startup companies. We focus on medical devices, healthcare IT, diagnostic biopharma and digital health technologies that will enhance patient safety and outcomes. Membership Inquiry.
We provide unparalleled access, mentorship and support to early-stage companies that have IP, a strong team, domain expertise and vision. Learn more about our Screening and Evaluation Process.
We are very excited to bring the best healthcare startup companies to light. These are companies that have IP, a seasoned and experienced team and are tackling big problems with innovative solutions. We also bring very knowledgable featured speakers to our events.
View Upcoming Events.
(Reuters) - Blood-testing company Theranos Inc said it plans to appeal the sanctions imposed by a U.S. regulator last month on one of its labs alleging its practices jeopardized patient health and safety. […]
DAR ES SALAAM (Thomson Reuters Foundation) - One of the biggest tests of Justine Michael's job as a community health worker is not the distances he must travel along remote dirt roads to visit patients in Tanzania's Mkuranga district, but rather the suspicion he often encounters. […]
(Reuters) - Recent clinical trial results are likely to lead doctors to treat more patients who have a common form of lung cancer with a Merck drug at the expense of a Bristol-Myers Squibb medication at least until more data emerges, oncologists and analysts say. […]
Amedica (NSDQ:AMDA) said yesterday it won expanded FDA clearance for additional sizes of its Valeo II lateral lumbar interbody fusion device. The Valeo II lateral lumbar fusion device is made out of proprietary medical grade silicon nitride ceramic and includes 2nd-generation instrumentation for improved patient safety, the Salt Lake City, Utah-based company […]
Drug-coated balloon treatments reduce the risk of target lesion revascularization in treating femoropopliteal artery disease by 67% when compared to plain balloon angioplasty procedures, according to a new study. Results from the study were published in the Journal of the American College of Cardiology: Cardiovascular Interventions. The study aimed to compar […]
Coloplast (CPH:COLO B) is looking to expand its worker base in Minnesota, according to a new report from the Twin Cities Business Mag. The company, which acquired the urology business mentor Minnesota in 2006, has its North American headquarters in Minneapolis, Minn. with 310 employees in the area. Coloplast is looking to add an additional 3,000 staff […] Th […]
The FDA today released a safety communication warning of problems with lack of flow continuity when programmable syringe pumps are set to low flow rates. The federal watchdog released the safety notice for any practitioners who would operate or work with programable syringe pumps and those who administer high risk and life-sustaining medication therapies. Pr […]
...s employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. Forward-Looking Statements This release includes forward-looking statements concerning Baxter's REVACLEAR dialyzer and ... […]
...of trailblazing better ways to deliver services, and we are excited to be a part of this next wave of healthcare innovation." • "Patients are, first and foremost, consumers who increasingly use mobile devices in many aspects of their lives. Healthcare is ... […]
...s employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. View source version on businesswire.com: http://www.businesswire.com/news/home/20160815005881/en/ [ Back ... […]
...s employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. Forward-Looking Statements This release includes forward-looking statements concerning Baxter's Sigma Spectrum Infusion ... […]